Why Partner?
Looking to Position Yourself as a Leader in the Gene Editing Field?
As the only event dedicated to the drug development challenges facing new editing and delivery technologies in the gene editing field, this is your opportunity to establish brand excellence and forge relationships with industry leaders looking to meet expert service providers.
More and more companies are entering the space and require tried and trusted expertise to outsource to and source provisions from. From research this year, we know that industry leaders are eager to connect with organizations that provide services in the following domains:
CRISPR constructs, reagents, enzymes, and other key technologies
CRISPR-engineered cell lines, animal models, and human iPSC lines
Contract manufacturing organizations and vector providers
Legal firms with expertise in IP, FTO, patent disputes, and licensing deals
In return, we can provide you with a unique platform to showcase your capabilities, helping you forge a new network of potential clients and establish an edge over your competitors.
If you work to support gene editing drug development figures and are looking to position yourself as a market leader, this is the one meeting in 2024 you need to partner with.
Get in touch to explore how we can position your brand in front of 70+ leading biopharma companies.
A Snapshot of Attending Companies Last Year:
Who is This Event Designed For?
What Past Attendees Had to Say
“The talks and panels were outstanding, and the one-on-one interactions I had with attendees were extremely rewarding. The small size of the conference is a big strength: it's great to be in an intimate setting with peers who have such a depth of experience and expertise”
UC Berkeley
“It was great to be able to physically attend the conference and listen to the amazing research going on in the CRISPR field and see some of the data generated by top companies. I also felt it was a nice platform to meet like-minded people from the same field and network with them Verve Therapeutics.”
Verve Therapeutics
“An agenda that covered all the relevant aspects in the filled, gathering leading scientists from both industry and academia. This, combined with an atmosphere that encouraged networking and productive discussions.”
Emendo Biotherapeutics
